Beremagene geperpavec for treating skin wounds associated with dystrophic epidermolysis bullosa
Open for comments Open until Request commenting lead permission
We have updated this service so that members of the same organisation can now collaborate on a joint online response.
Read our blog to learn more.
4 Evaluation committee members and NICE project team
Evaluation committee members
This topic was evaluated as a single technology appraisal by the highly specialised technologies evaluation committee. The highly specialised technologies evaluation committee and the 4 technology appraisal committees are standing advisory committees of NICE. Committee members are asked to declare any interests in the technology being evaluated. If it is considered there is a conflict of interest, the member is excluded from participating further in that evaluation.
The minutes of each evaluation committee meeting, which include the names of the members who attended and their declarations of interests, are posted on the NICE website.
NICE project team
Each evaluation is assigned to a team consisting of 1 or more health technology analysts (who act as technical leads for the evaluation), a technical adviser, a project manager, and an associate director or principal technical adviser.
Alan Moore
Technical adviser
Thomas Feist
Project manager
Christian Griffiths
Principal technical adviser
ISBN: [to be added at publication]
How are you taking part in this consultation?
You will not be able to change how you comment later.
You must be signed in to answer questions
Question on Consultation
Question on Consultation
Question on Consultation
Question on Consultation